Night time blood pressure in diabetic patients - The submerged portion of the iceberg?

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1061-1064

  Sehernthaner, Guntram ^d   Ritz, Eberhard ^a,d,e   Philipp, Thomas ^b,d   Bretzel, Reinhard G ^c,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Div of Nephrology and Hypertension   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d Rudolfstiftung   (Austria)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY MONITORING; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DIABETES MELLITUS; EDITORIAL; HUMAN; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMANS;

EID: 0032922512     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1061     Document Type: Editorial

References (18)

1. Schnack CH, Scheithauer W, Gisinger CH, Winkleer J, Schernthaner G. Prevalence of microalbuminuria in maturity onset primarily non-insulin requiring diabetes mellitus: effect of disease duration, glycemic control, and mean systemic blood pressure. J Diabetic Complications 1987; 1: 132-136
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 1991; 265: 3255-3264
3. Hansson L, Zanchetti A, Carruthers SG et al. for the HOT Study Group. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1988; 351: 1755-1762
4. UK Prospective Diabetes Study (UKPDS) Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1988; 317: 713-719
5. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-713
6. Pickering TK, James GD, Boddie C. How common is white coat hypertension? J Am Med Assoc 1988; 259: 225-228
7. Sturrock ND, Pound N, Peck GM, Soar CM, Jeffcoate WJ. An assessment of blood pressure measurement in a diabetic clinic using random-zero, semi-automated, and 24 hour monitoring. Diabetes Med 1997; 14: 370-375
8. Nielsen FS, Gaede P, Vedel P, Pedersen OB, Parving HH. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabetes Care 1997; 20: 859-863
9. Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G. Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertension 1996; 9: 1139-1143
10. Poulsen PL, Beck T, Ebbehoi E, Hansen KW, Mogensen CE. 24 h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia 1998; 41: 105-110
11. Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 1994; 43: 1248-1253
12. Poulsen PL, Ebbehoi E, Hansen KW, Mogensen CE. 24 hour pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 1997; 40: 718-725
13. Nakano S, Fukuda M, Hotta F et al. Reversed circadian blood pressure rhythm is associated with occurences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47: 1501-1506
14. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Morning peak in the incidence of myocardial infarction experience in the ISIS-2 trial. Eur Heart J 1992; 13: 594-598
15. Fagerudd JA, Tarnow I, Jacobsen P et al. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 1998; 47: 439-444
16. Strojek K, Grzeszczak W, Morawin E et al. Nephropathy in type 2 diabetes: evidence for hereditary factors? Kidney Int 1997; 51: 1602-1607
17. Chen JW, Jen SL, Lee WL et al. Differential glucose tolerance in dipper and nondipper essential hypertension. Diabetes Care 1998; 21: 1743-1748
18. Schernthaner G, Ritz E, Philipp Th, Bretzel R. Die Bedeutung der 24-Stunden Blutdruckmessung bei Patienten mit Diabetes mellitus. Dtsch Med Wochenschr (in press)